← Eichor
Condition: Viral Pneumonia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Viral Pneumonia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
Phase 3 · 28 location(s) · Jena University Hospital · NCT06134492Covid-19 and Influenza Oral Vaccine Study
Phase 1 · 1 location(s) · Vaxine Pty Ltd · NCT06355232Arginine Replacement Therapy in COVID-19
Phase 2 · 1 location(s) · Emory University · NCT05855330Health Care Workers Cohort Study in the EuCARE Project (EuCARE-HCW)
Phase N/A · 7 location(s) · Euresist Network GEIE · NCT05534009Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT06160128Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
NA · 33 location(s) · Unity Health Toronto · NCT03963622Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)
Phase N/A · 1 location(s) · Instituto de Investigación Biomédica de Salamanca · NCT07295483Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
Phase 1 · 1 location(s) · Stephanie B. Seminara, MD · NCT07224490Immune Defense Protein Impact On Respiratory Immune Outcomes
NA · 1 location(s) · Quantec Ltd · NCT07431840Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Phase N/A · 1 location(s) · University of Oxford · NCT05571735Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Phase 1 · 2 location(s) · Shionogi · NCT07093580A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Phase 4 · 6 location(s) · ModernaTX, Inc. · NCT06585241Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
NA · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04558450Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07359482Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Phase 1/Phase 2 · 1 location(s) · Thomas Advanced Medical LLC · NCT04684602Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia
Phase N/A · 1 location(s) · Osijek University Hospital · NCT05181696Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatig
Phase N/A · 1 location(s) · Instituto Nacional de Rehabilitacion · NCT06864156Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05233605The Role of Obesity in Severe COVID-19 Pathophysiology
NA · 1 location(s) · Franciscus Gasthuis · NCT06968442A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Phase 3 · 148 location(s) · Pfizer · NCT07013474Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04794829Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
NA · 4 location(s) · KidSIM Simulation Program · NCT05868239Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
Phase N/A · 1 location(s) · The Geneva Foundation · NCT06402318Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
Phase 1/Phase 2 · 1 location(s) · All Natural Medicine Clinic, LLC · NCT04790240Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
NA · 1 location(s) · Yale University · NCT05796505A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Ge
Phase N/A · 1 location(s) · Pfizer · NCT05890612Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
NA · 1 location(s) · Johns Hopkins University · NCT06128928Taurine Supplementation in Long COVID
Phase 2/Phase 3 · 5 location(s) · University of Alberta · NCT06721949Telecommunication Technology-based Online Survey
Phase N/A · 1 location(s) · Tomsk National Research Medical Center of the Russian Academ · NCT06159699
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.